Inmunotek
PrivateLast Round
Grant
Dec 1, 2025
Total Funding Raised
$1.94M
Company Overview
Inmunotek is a Spanish biopharmaceutical company that researches, develops, manufactures, and commercializes products for the diagnosis and treatment of diseases in the fields of allergy and immunology for both human and veterinary use.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inmunotek Comps
Public and private peers based on sector, stage, and business model.
Inmunotek Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 1, 2025 | ||||
| Grant | Jul 1, 2024 |
Inmunotek Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2025
Received funding from CDTI Innovation and ERDF.
- Jul 1, 2024
$1.94M grant received from Fondo de Apoyo a la Inversión Industrial Productiva.
Inmunotek Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inmunotek's valuation, stock price, and market status.
